Placental hematopoietic stem cell
Placental hematopoietic stem cells are the original hematopoietic stem cells derived from placental tissue, which is the originator of all blood cells (red blood cells, white blood cells, platelets), and is the core part of the human hematopoietic system. At present, hematopoietic stem cell transplantation is an effective treatment for hematological diseases such as malignant hematological diseases.
unamplified
The baby doesn't have to be a match
Family matching rate is high
Major advantage
Abundant quantity: breaking through the use bottleneck of cord blood hematopoietic stem cells with a weight of 30 kg, which can be enough for adult use;
High matching rate: consistent with the baby's HLA matching, the baby does not need to use matching, and the success rate of matching by family members is as high as 25%-50%.
Primary indication
Hematologic malignancies (chronic myelogenous leukemia, acute myeloid leukemia, acute lymphoblastic leukemia, non-Hodgkin lymphoma, etc.)
Non-malignant hematological diseases (aplastic anemia, Fanconi anemia, thalassemia, sickle cell anemia, myelofibrosis, etc.)
Immune deficiency (severe combined immunodeficiency, severe autoimmune disease, etc.)
